Navigation Links
Researchers hope to provide chronic fatigue syndrome answers
Date:12/18/2007

One of the most difficult things for people suffering from Chronic Fatigue Syndrome (CFS) is that many believe the condition to be a psychological, not physical affliction.

New research by the Faculty of Kinesiology hopes to measure one of the syndromes most obvious symptoms information that could help doctors in the diagnosis CFS.

Diagnosis of the syndrome, generally follows eliminating every other possible cause, which leads some to speculate that the condition isnt real, says Dr. Brian MacIntosh. One thing we know is that CFS sufferers feel profound fatigue and worsening of other symptoms following even moderate physical activity. Using our expertise in the field of exercise physiology we believe we can measure this post exertion malaise and say with certainty if an individual has recovered from exercise or if that activity is making them even more fatigued.

MacIntosh, who is the Faculty of Kinesiologys Associate Dean of Graduate Studies, is an expert in the area of muscle fatigue. Much of his research has centered on high-performance athletes in peak physical condition, however he says that this research fits in well with his overall area of interest.

The tools we have developed in high performance sport are perfectly suited to track muscle fatigue in this application so without question we will be able to get some concrete answers, he says.

The research trial will put CFS patients on a stationary bike to perform a VO2 Max test similar to trials used to evaluate the fitness level of professional athletes. The individual will pedal to the point of fatigue, at which point researchers will take several measurements including a blood sample in which lactate will be quantified. The next day the patient will return and follow the same workout protocol.

Most healthy individuals should be able to easily match their performance from the previous day, MacIntosh explains. Since CFS patients by definition report
'/>"/>

Contact: Don McSwiney
dmcswine@ucalgary.ca
403-220-7652
University of Calgary
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...STANFORD, Calif. A new study shows that muscle ce...ility to squeeze shut properly. The work, performe...tients with conditions such as gastric reflux and ... to strengthen sphincters, which are the bands of ...testinal tract. Weakness in these areas can cause ...
(Date:12/4/2009)...e, MD "Why is it that men can be bastards and wo... Hecht Schafran. The answer, according to an artic...rpretation of facial expressions. , In two studi... of a series of faces. In the first study, androgy...ngry expressions) were more likely to be identifie...
(Date:12/4/2009)...ponse to pressure from federal regulators to crack... FRIDAY, Dec. 4 (HealthDay News) -- The makers of ...esented federal regulators with plans to curb the ...cal companies have been under pressure from U.S. F...y to stop the hundreds of fatal overdoses that occ...
(Date:12/4/2009)...e H1N1 virus will come back during winter isn,t kn...thDay News) -- The number of states reporting wide...s week -- to 25 from a high of 48 just two weeks a...hile, the supply of H1N1 swine flu vaccine continu... the U.S. Centers for Disease Control and Preventi...
(Date:12/4/2009)...y found they spurred blood vessel growth after hea...News) -- Adult stem cells appear to help repair he...se 1 study of 53 patients found that stem cells fr...ood vessels in heart tissue damaged by heart attac...ions within 10 days of having a heart attack. Duri...
Breaking Medicine News(10 mins):Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
...,Corporation (NYSE: SYK ) announced today that it...ence: September 25, 2007 - 4:30 p.m. Eastern Time...ew York A simultaneous webcast of the Company,s p...l be archived for 30 days. Certain statements mad...
...edited for removing requirement for,"dangerousness...vich has signed Senate Bill 234 into law, to the e... improve the state,s strict mental illness,treatme...ss treatment. The new law, which will go into effe...
...anning Corporation,today announced the introductio...ic derivative of its patented GlobalTrak(R) asset ...the rigorous tracking and monitoring,requirements ...anufacturer to distributor to retailer or,clinical...
...cs,Corporation (Nasdaq: DYNT ) today announced re... June 30, 2007. Net income for the fourth quarter,...o $39,101 ($.00 per,share) in the fourth quarter o...ere $17,837,104, compared to,$19,513,136 in the pr...
... examines various state initiatives to expand acce...e President and Congress in support of state effor...of Physicians (ACP). , The paper, State Experim...f state efforts to reform health care and recommen...
...ard of,directors of Abbott today declared a quarte... marks the 335th consecutive quarterly dividend to...s payable Nov. 15, 2007, to,shareholders of record... development, manufacture and marketing of pharmac...
Other Medicine News:Health News:Stryker to Present at Investor Conference 2Health News:Gov. Blagojevich Signs Bill Improving Illinois' Mental Illness Treatment Law 2Health News:System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 2Health News:Dynatronics Announces Strong Fourth Quarter Profit 2Health News:Dynatronics Announces Strong Fourth Quarter Profit 3Health News:Internal medicine physicians recommend key elements to guide state initiatives 2Health News:Internal medicine physicians recommend key elements to guide state initiatives 3
(Date:12/3/2009)...wire-FirstCall/ -- Allen Medical Systems, a subsid...day announced the launch of its new Allen Amatech(... website www.AllenAmatech.com . ,, The webs...y and includes an online version of the new produc...pecifications for the products. "We hope to make t...
(Date:12/3/2009)...wire-FirstCall/ -- A genetic variation that may in...y life-threatening blood disorder if exposed to ce... of several medical discoveries scientists at canc...GX ) will present during the 51st American Society..., December 5-8, 2009, in New Orleans, LA. ,, I...
(Date:12/3/2009)... Ted Karkus, Chairman and... www.quigleyco.com announced today that the Compa...es to develop prescription pharmaceutical and OTC ...interests to focus primarily on the OTC/Personal C...ited to its Cold-EEZE® and Kids-EEZE® br...
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3Cinergy Health Commentary on Americas Prescription Addiction 50331 1Cinergy Health Commentary on Americas Prescription Addiction 50331 2Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 1Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 2Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 3
...Pharmaceuticals, a division of Wyeth (NYSE: WYE )...INvestigation of TORISEL and Avastin,Combination T... phase 3b,study comparing TORISEL(R) (temsirolimus...s interferon-alfa for first-line treatment of pati...th Research is conducting the,INTORACT study with ...
... Important Factor When Selecting Treatment ... - ABSTRACT No: 5110 (Poster 6H), BASEL, S...oncology meeting in the world, the American Societ...s of managing side effects in patients,with metast...ib (Sutent(R)),are two to three times greater than...
Other Medicine Technology:Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 2Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 3Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 4Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 2Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 3
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: